2 results about "Tebufenpyrad" patented technology

The present application relates to a synergistic composition containing a biologically effective amount of compound A and component B, wherein the component B is one of thiazide ketone, avermectin, spirotetramat, pyridalyl, emamectin benzoate, azamethiphos, azocyclotin, pyridaben, quimacryd thiocyl, pyrimidifen, tebufenpyrad, flufenoxuron, chlorfenapyr, cyromazine, and halofenozide, and a method thereof for controlling pests in agronomic and non-agronomic environments. The compound A has a synergistic effect with the component B, which can improve the pest control effect, reduce the application amount, reduce the use frequency, and reduce the use cost.

The application discloses a novel thiacloprid and ochratoxin A recognition element bispecific antibody preparation and application in enzyme-linked immunosorbent assay synchronous detection, and belongs to the technical field of molecular biology. The application provides a thiacloprid and ochratoxin A bispecific antibody, which is expressed in Expi293F cells and used for preparing an ELISA detection reagent, so that the bispecific detection of thiacloprid and ochratoxin A can be effectively realized. The linear ranges of the bispecific antibody provided by the application for detecting thiacloprid and ochratoxin A are 0.05-1000 ng / mL and 0.05-500 ng / mL respectively, and the IC50 is 17.10 ng / mL and 16.69 ng / mL respectively.